EKF Diagnostics (LON:EKF) Shares Cross Below Two Hundred Day Moving Average of $29.20

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 29.20 ($0.37) and traded as low as GBX 27.18 ($0.34). EKF Diagnostics shares last traded at GBX 28.05 ($0.35), with a volume of 116,932 shares.

EKF Diagnostics Price Performance

The stock has a 50-day simple moving average of GBX 29.97 and a 200 day simple moving average of GBX 29.20. The company has a current ratio of 2.69, a quick ratio of 1.77 and a debt-to-equity ratio of 6.01. The stock has a market capitalization of £127.27 million, a price-to-earnings ratio of 2,805.00 and a beta of 0.56.

EKF Diagnostics Company Profile

(Get Free Report)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

See Also

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.